SCHEMBL10094405

SCHEMBL10094405

CC(C)c1ccc(F)cc1-c1cnn(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR55 Q9Y2T6 1/20 0.46
▸ LRRK2 Q5S007 1/20 0.42
▸ NTRK1 P04629 2/20 0.41
▸ NTRK3 Q16288 2/20 0.41
▸ ALK Q9UM73 2/20 0.41
▸ ALOX5AP P20292 1/20 0.41
▸ FEN1 P39748 1/20 0.41
▸ BRD4 O60885 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ CLK1 P49759 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ IRAK1 P51617 1/20 0.38
▸ IRAK4 Q9NWZ3 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ TGFBR1 P36897 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ TYK2 P29597 1/20 0.38
▸ JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26505596 0.88 GPR55 (0.46) GPR55LRRK2NTRK1NTRK3ALK
SCHEMBL18124158 0.81 TGFBR1 (0.48) GPR55LRRK2NTRK1NTRK3ALK
SCHEMBL10094435 0.80 PDK2 (0.44) NTRK1IRAK4PDK2
SCHEMBL17806620 0.80 ALOX5AP (0.41) GPR55LRRK2ALOX5APFEN1BRD4
SCHEMBL10094634 0.80 LRRK2 (0.48) GPR55LRRK2ALKALOX5APFEN1
SCHEMBL23761250 0.79 ALOX5AP (0.44) GPR55LRRK2NTRK1NTRK3ALK
SCHEMBL20754515 0.79 ALOX5AP (0.42) GPR55LRRK2NTRK1NTRK3ALK
SCHEMBL31677710 0.78 LRRK2 (0.50) GPR55LRRK2ALKALOX5APFEN1
SCHEMBL10094326 0.78 BRD4 (0.50) ALOX5APFEN1BRD4IRAK1IRAK4
SCHEMBL17806593 0.77 KCNH2 (0.49) GPR55ALOX5APFEN1CLK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 — — US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 GPR55 1965/4885LRRK2 778/4885NTRK1 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback